Joseph Tarsia, MD is a board-certified vascular neurologist who directs the Cerebral Amyloid Angiopathy (CAA) Clinic at the Ochsner Neuroscience Institute in New Orleans, Louisiana. He evaluates and treats patients with cerebral amyloid angiopathy, including CAA-related inflammation (CAA-ri), brain hemorrhage, convexal subarachnoid hemorrhage, amyloid-related imaging abnormalities (ARIA) or complications from anti-amyloid therapy, transient focal neurological episodes (also called amyloid spells) and the spectrum of vascular cognitive impairment. While CAA is the focus of his practice, Dr. Tarsia evaluates the full range of complex conditions affecting the brain's smallest blood vessels, including hypertensive brain bleeds and lacunar strokes, with microvascular brain health as the organizing focus of his clinical and research work. Working in close collaboration with Ochsner's cognitive and behavioral neurology team, he brings precision to diagnosis and a commitment to helping patients understand and navigate what it means. 

Dr. Tarsia is Program Director of the Vascular Neurology Fellowship at Ochsner Neuroscience Institute, is a Senior Lecturer at the University of Queensland Ochsner Clinical School and is dedicated to the neurology resident educational mission. He also chairs the Community Outreach and Education Steering Committee of the International CAA Association. A New York native, Dr. Tarsia earned his undergraduate degree from Johns Hopkins University before graduating from Tulane University School of Medicine in 2010. He completed a five-year combined Neurology and Internal Medicine residency at Tulane, where he served as chief resident, followed by a Vascular Neurology Fellowship at Harvard Medical School - Beth Israel Deaconess Medical Center in Boston. He joined the Ochsner Neurovascular Program in 2016, is board certified in neurology and vascular neurology and is a certified hypertension specialist. 

Request an cerebral amyloid angiopathy appointment here.